Biotech,

Pharmaceuticals
and Medical
Devices
Global Biotech, Pharmaceuticals and Medical
Device Industry
 Biotech Industry - Global Overview
The expected global biotechnology market size: USD
414.5 billion by 2017

Revenues reach historic high: USD 132.7 billion

The biotech industry market cap: USD 863 billion in

2016
Capital raised: USD 71 billion

Innovation capital exceeds USD 41 billion

M&A involving biotech >USD 100 billion

R&D spend ↑ 16% to >USD 45 billion

Year-over-year percentage change in financial indicators (US &

100
250 Europe)

75 65
Percentage

50
28
25 18 18 14 17 16
12 13
5
0

-25 -15
Revenues Profitability R&D Market capitalization
2013 2014 2015

Global Biotechnology market has been segmented by

Technology Application Geography

► Fermentation Technology ► Biopharmacy ► NorthAmerica

► Tissue Engineering and ► Bioservices ► Europe
Regeneration Technology ► Bioagriculture ► Asia Pacific
► Polymerase Chain Reaction
► Bio industrial ► Rest of the World
Technology
► Nanobiotechnology
► Chromatography

► DNA Sequencing Technology

► Cell based Assay
Source: Biotech Spain, EY Global Biotech Report 2017

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 3
 Global Overview
2000 versus 2017
Revenues of Top 10 US biotech firms

USD 11.8 billion  USD 321 billion

Total US and European revenues

+650%
European commercial leaders

211
US commercial leaders

717
The Value Chain – Global Biotechnology Industry

Inbound Logistics Operations Outbound Logistics Marketing & Sales

Stem cells
Hospitals
Trade shows

Serum Advertisements
Pharmacy

Bacteria

Culture • Research Clinics

• Clinical Testing
• FDA review
• Patenting and
Manufacturing

Supporting Activities
► Procurement and Technology development
► The industry is highly technology driven and research intensive. Certain material can be brought from
only from specific agencies that provide quality products at competitive prices
Source: www.statista.com

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 4
 Medical Devices - Global Overview
The Medical Device market is forecast to grow, from $12 billion in 2013 to $17.5 billion by 2020, at a CAGR of 4.8%

Medical Devices Market: Forecast for Growth (USD in billions)

Region 2016 2017 2018 2019 2020
Americas 166.6 176.5 187.3 197.9 208.6
Asia/Pacific 68.7 72.6 77.6 82.9 88.6
Central/Eastern 14.6 15.7 17 18.1 19.1
Middle East/Africa 10 10.8 11.5 12.5 13.2
Western Europe 79.5 85.1 92.6 101.4 106.2
Total 339.5 360.8 386.1 412.8 435.8

US continues to dominate the global medical devices market, with India and China having the highest
growth rate

CAGR
+9.1%
7 11
CAGR
+4.2%
2013 2018
64 79

CAGR
2013 2018 +2.5%
CAGR
30 34
+5.6%
12 16
7 7
2013 2018

2013 2018 CAGR

CAGR
+18.7%
+20.0%

CAGR
9 40
+13.2% 4 17
Medtech market size
(US$ billion) 2013 2018 2013 2018
6 11

2013 2018
CAGR – Compound annual growth rate

Source: Worldwide Medical Devices Forecast to 2020, Espicom Country Reports

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 5
 Pharma Industry - Global Overview
• Develop, produce and market drugs for use as
medications

• May deal in generic or brand medications and

medical devices

• Subject to variety of laws and regulations that

govern the patenting, testing, safety, efficacy and
marketing of drugs

• Main goal is to produce drugs that prevent

infections, maintain health and cure diseases

Pharma market development Global Pharma Segment Sales

2006-16 (USD) (USD billions)
1000 1500

1000
500
500
0 0
2006 2011 2016 2010201120122013201420152016201720182019
Emerging markets Rest of the world Pharmaceutical Sales

The Pharma emerging markets are defined by the IMS as countries with greater than 1 USD billion absolute
spending growth of more than 2012-2016 and which have GDP per capita of less than USD 25000 at
purchasing power parity

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 6
Biotech, Pharmaceuticals and Medical Device
Industry in India
 India Overview

Indian biotech industry is expected to grow at 30.46 percent CAGR to reach USD
100 billion by 2025

► The Biotechnology Industry has grown from

$1.1 billion in 2005

► The bio-pharmaceutical sector accounts for the

largest share of the biotech industry with a
share of 62% of total revenues in 2015.

Indian Pharmaceutical sector FDI Equity Inflows in Drugs and Pharma

accounts for about 2.4 per cent (in USD million)
of the global pharmaceutical
7,000
industry in value terms and 10 880.5
6,000
per cent in volume terms 765.4
5,000
4,000
3,000
Drugs and Pharmaceuticals is 278.6
2,000
the among the top sectors is
1,000
India attracting highest FDI
0
Equity Inflows 2015-16 2016-17 2017-18
Up to June 2017
► Share in global pharmaceutical production is nearly 8% Source: DIPP 2017

India is a global leader in production of generic drugs

► Expected to be 3rd largest global generic Active Pharmaceutical Ingredient (API) merchant market

► Constitutes 70% market share, largest segment of Pharmaceuticals

► India supplies 20% of global generic medicines market exports in terms of volume

Investment planned for medical infrastructure by 2024 is USD 200 billion

Key Segments

► API Manufacturers/Traders ((Bulk Drugs)

► Formulation Manufacturers
► Contract Research and Manufacturing Services Companies
► Biotechnology Companies
Source: Pharmaceuticals- March 2017. https://www.ibef.org/download/Pharmaceutical-March-2017.pdf

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 8
 Value Chain: Pharma

Marketing

Manufacturing

Manufacturing Pharmaceutical manufacturing

Active Ingredients Additives
Formulations Filling Packaging
(API’s/Bulk Drugs) (Intermediaries)

Drug development

Integration
Clinical trials Regulatory filings

Drug Discovery

NCE NDDS Reverse engineering

A company can operate in any one niche area or be

Source: EY Research integrated across the value chain

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 9
 Indian Market
Biotech Industry
Market Size of Biotech Industry
► Industry is growing at a CAGR of 20.33% (US$ billion)
► Year on Year growth of 57.14 per cent in FY16 14
► Total industry size stood at US$ 11 billion by FY16 and 12 11 11.6
is estimated to have reached US$ 11.6 billion by FY17 10
► Growth driven by factors such as growing demand, 8 7
intensive R&D activities and strong government 6 5
4.3
initiatives. 4
► Clinical capabilities are developing fast and the country 2
is becoming a popular destination for clinical trials, 0
contract research & manufacturing activities FY 13 FY 14 FY 15 FY 16 FY 17 E

Pharmaceutical Market

Share of Indian generic exports in global 80.0 Indian Pharma Industry US$69.7
generic market, 2015-16 billion
70.0 CAGR: 11.4%
60.0 21.7
50.0 US$40.6
billion
Indian 40.0 21.0
companies, 30.0 12.9
4.0% 20.0 11.7
10.0 27.0
16.0
0.0
2015 2020F
Domestic formulations Formulation exports
API exports
Source: Pharmexil Annual report, 2015-16
Source: EY Research

► By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and
6th largest market globally in absolute size.
► The generics market stood at US$ 26.1 billion in 2016.
► Low cost of production provides competitive edge over others.

Source: Indian Medical Device Market Outlook, 2017

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 10
 Indian Market
Medical Devices

► India is among one of the top 2- global medical device markets and 4th largest in Asia

► The market stood at around US$ 5.1 Billion

in 2012, is expected to grow at a rate of
around 16% during 2012-2017,
representing one of the fastest growing
medical devices markets in the world
► The sector received a total of INR 8344
9
8 8.2
7 7
6 6.1

USD Billion
Crore (approx. USD 1452 Million) between 5 5.2
2000 and 2016*, reflects the confidence of 4.5
4 3.9
global players in the Indian market 3 3.2 3.2 3.4
► Device market mainly dominated by 2.5 2.8
imports (almost 70%) 2 2
► Significant percentage of buyers of medical 1
devices are private medical institutions and 0
hospitals

Market Size USD Billion

► Market has grown to USD 2.02 billion in

2009 to USD 3.89 billion in 2015 at CAGR Growth Factors
of 15.8%.
► Constitutes nearly 1.7% of the global ► Growing Population
device market in 2015 ► Ageing Population
► Indian market contributes to 4% of Indian ► Increasing Disease Burden of Chronic Diseases
healthcare market which is pegged at USD ► Increasing Health Insurance Penetration
96.7 billion ► Growing Medical tourism
► Demand for Healthcare Infrastructure
Key Segment ► Emerging Healthcare Service Formats
► Quality and Accreditation of Hospitals as par with
► Diagnostic imaging is the largest segment International Standards
in 2015
► Constitutes USD 1.18 billion in 2015 and
will grow to USD 2.47 billion in 2020
► Other and IV diagnostics comprises
electrical and electronic devices
► Orthopedics & Prosthetics and
Consumables will grow from USD 0.09
billionin 2015 to USD 1.88 billion in 2020
► Dental Products and Patient Aids will grow
from a cumulative USD 0.47 billion in 2015
to USD 1.1 billion in 2020

Source: Indian Medical Device Market Outlook, 2017, Annual Report 2016-17, Ministry of Chemicals & Fertilizers

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 11
 Policy Regulations
Key Milestones in Indian Pharma Sector

Before 1970

► Low domestic 1970-90

production and ► Indian Patent 1990-2010
market Act, 1970 ► Market liberalized 2010 and beyond
participation; ► Domestic to promote
market production and imports and ► The National
dominated by participation domestic Pharmaceutical
global/foreign increases with production Pricing Policy, 2012
companies increase in ► Patents (NPPP-2012)
production (Amendment) Act,
infrastructure ► Essential drug list
2005, leading to expanded
► India began adoption of
pharmaceutical product patents in ► Patent-related
exports India; attracts rulings against
global evergreening, and
pharmaceutical compulsory
community licensing
► 100% FDI allowed ► Proposed one-tax
in pharmaceutical regime (GST), to be
sector implemented by
2016

Investment Intentions in terms of IEMs Filed, LOI/DILs Issued

Categories 2015 2016 2017

No.s Proposed No.s Proposed No.s Proposed
Investment Investment Investment
(INR crores) (INR crores) (INR crores)
Medical and Surgical 9 200 14 224 3 442
Instruments
Drugs and Pharma 79 6660 103 13952 71 6055
Source: Department of Industrial Policy and Promotion

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 12
Karnataka’s Biotech, Pharmaceuticals and
Medical Device Industry
 Karnataka’s Unique Advantages

Knowledge Hub
for
Biotechnology

► Karnataka is the number 1 biotech hub in India with revenues of $ 6.5 bn in 2015
► Karnataka Accounted for 35% of India’s Biotech Industry Revolution
► Biopharma is the biggest segment of biotech industry (~60%)

Biotech Units in
Karnataka 380 + 194
Companies + Start-ups
► It is home to over 60% of the country's Biotech companies
► State accounts for 54% of India’s Biotech Workforce
► Biotech start-ups growing at 30% annually in the state
► Karnataka contributes to around 1/3rd of the BT exports of the country
► First state in the country to bring out biotech policy. Version 3 of the policy announced
recently
► Bio-Ventures Fund of INR 50 crores (USD 1 bn)
► Bengaluru Bio Innovation Centre established with state-of-the-art incubation facilities
► 7500+ Biotech Graduates every year
► Institute of Bio informatics and Applied Biotechnology (IBAB) offering courses for PG,
M.Sc, and PhD
► R&D group in the area of Synthetic Biology is in the process of establishment in IBAB
► Centre for Human genetics in Bengaluru Helix Park offers training in Genes analysis
particularly in area of Rare Genetics Disorders
► Ganit Lab setup in Bangalore Helix Park is the only one of its kind in the country
engaged in research and training in Bio-IT
► Institute of Agri-biotechnology setup in Dharwad
► Biotech Finishing Schools established in 12 educational institutions to provide
industry-ready graduates. Second phase of the programme- Biotechnology Skill
Enhancement Programme (BiSEP) taken up in 18 educational institutions
► Karnataka has the highest R&D expenditure in south India (3rd in the country)
► Incubation Centres for Biotech Start-ups being setup in Tier-2/3 cities
► Launched grand challenges scheme under the start-up policy for Biotech sector
► Research labs under green category

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 14
 Karnataka’s Unique Advantages

Karnataka’s
Karnataka’s Pharma Industry Pharmaceutical Industry
manufactures Bulk Drugs,
Formulations and Medical devices

► General Dosage Forms: Tablets, capsules,

Parenteral Preparations, liquid orals, API’s
Diagnostic Kits, Dialysis Fluids, Vaccines
► Specialized categories: rDNA Products Soft
► Karnataka contributes around 10% to
gelatin Capsules, Eye Drops, FFS, medical the country's revenue in the
Devices, cardiac Stents, Drug Eluting Stents, pharmaceutical sector.
Orthopedic Implants, Oral; & mechanical
Contraceptives ► The state has exclusive pharma
SEZs in Hassan and Yadgir
Basic Chemicals, Pharmaceuticals &
cosmetics Export Scenario in INR crore ► Karnataka ranks 5th in pharmaceutical
(USD bn) exports, contributing 12% to country's
exports.
2016-17* 5,349 (82)

2015-16 10,828 (167) ► A well developed research base with

presence of 35 Clinical Research
2014-15 5,896 (91) Organizations (CROs) and 12
2013-14 8,300 (128)
Adverse Drug Reaction Reporting
Centres (ADR) assisting the industry
2012-13 7,233 (111) with clinical trials and research
2011-12 5,077 (78)
► Initiatives like Venture Capital fund of
2010-11 2,893 (45) INR 50 crore (USD 1 bn) with 26%
contribution from government,
2009-10 2,761 (42)
formation of Karnataka
2008-09 2,531 (39) Pharmaceutical Development Council
and the Vision Group and
2007-08 2,070 (32)
promotional activities have been
0 2,000 4,000 6,000 8,000 10,000 12,000 introduced in the policy.
* Upto September 2016
Source: Economic Survey of Karnataka 2016-17

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 15
 Driving Growth: Infrastructure Support

Bio Innovation
Clusters with
investment of
USD 20 mn
each

Nutri/
Nutraceutical
Marine Biotech Animal Biotech Bangalore Bio
Agri Biotech and Phyto-
Park, Park, Vivarium, Innovation
Park, Dharwad Pharmaceutical
Mangaluru Bidar Centre (BBC)
Park (N2P2),
Mysore

Animal BT Park ► Location – Bidar

► Location - Dharwad
► R&D in disease diagnosis.
► R&D on gene Vaccine production,
construction. Drought Embryotransfer,
tolerance, Anti phyto Bionformatics, stem cell
pathogenic genes techniques etc.
etc.
► Collaborator – KVAFSU,
► Collaborator – UAS Bidar
Agri Biotech Park

Bangalore Bio
Innovation Centre
Marine Biotech Park
► Location – Mangaluru ► Currently operational
► R&D on DNA ► Common Instrumentation
sequencing, up scaling facility
technology processing ► 25 SMEs with access to
waste utilization high tech instrumentation
N2P2
► Collaborator – College facility
of Fisheries/ KVAFSU

► Location – Mysuru
► R&D facility to develop
various nutrition and phyto
pharmaceuticals
► Collaborator – CFTRI

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 16
 Driving Growth: Infrastructure Support

►Exclusive Pharma Industrial areas and Pharma SEZ at Hassan and Yadgir
►Pharma Park at Mangaluru
►Pharma and MedTech Zone to be set up in Bengaluru
►Pharmaceuticals Cluster, Kolhar Indl. Area, Bidar Dist (proposed)

► Location – Bidar
Pharmaceutical SEZ in Yadgir
► Pharmaceutical Cluster in
Kolhar Industrial Area

GSK Pharmaceuticals is
establishing one of the world’s
largest greenfield tablets and
capsules manufacturing facility
Pharmaceutical SEZ in Hassan at Vemgal in Kolar District,
Karnataka, with an estimated
investment of INR 1,000
crores (USD 15 bn)

Pharma Park at Mangaluru

Infrastructure Development:
PPP based Pharma SEZs
and Technology Parks that
will include

► General infrastructure,
biotechnology finishing
schools and commercial
space
► Manufacturing units for bulk
drug formulation and
development of medical
devices
► Research and Development
Centres
► Industrial Training Centres
and PPP based vocational
training programs
► Centres of Excellence
► Innovation and Incubation
Centres for Startups
► Exclusive Pharma industrial
areas in Hassan and
Yadagir

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 17
 Manufacturing in Karnataka

Leading Pharmaceutical Brands manufactured in Karnataka

►Crocin tablets and syrup ►Disprin tablets ►Ecosprin tablets
►Calpol drops ►Zental suspension ►Nizral solution
►Becosules capsules ►Beplex Forte ►Renerve
►Voveran tablets ►Corex cough syrup
►Benadryl syrup ►Listrine mouth wash

Major Players

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 18
 Manufacturing in Karnataka
Companies manufacturing Medical Devices in Bengaluru, Karnataka

Companies Products Location

Skanray technologies High frequency x-ray imaging Bengaluru

systems, critical care device
Healthium Medtech Pvt. Ltd. Suture Products and Consumables Bengaluru,
Tumakuru
BPL Medical Technologies Pvt. Electrocardiographs, patient Bengaluru
Ltd. monitors, defibrillators, central
nursing stations, stress test systems,
oxygenators, ultrasound scanners,
colposcopes, foetal monitors, foetal
Doppler and X-Rays
Forus Health Pvt. Ltd. Designing and service deployment of Bengaluru
healthcare equipment
2mpower Health Management Developing wearable devices Bengaluru
Services Pvt. Ltd.
Embrace Innovations Inc. Medical devices like infant warmers, Bengaluru
etc.
One Breath India Pvt. Ltd. Mechanical ventilator Bengaluru

S3V Technologies Pvt. Ltd. Cardiac stents Mysuru

Browndove Healthcare Pvt. Ltd. Catheters Bengaluru

Other Players in to manufacturing of Medical Devices in Karnataka

►GE healthcare ►Opto Circuits
►Medived ►Biorad Medisys
►Biget Labs ►Vascular Concepts
►Prognosys Medical, ►Confident Dental Equipment

Major Players

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 19
 Conducive Policy Environment

Karnataka
Biotech Policy
2017-2022

Creates specific Infrastructure –

1 2
focused biotech parks in the area of Simplified administrative procedures
agriculture, marine biotech and animal and special incentives
husbandry

► Bangalore Bio Innovation centre with 25 ► Single-Window clearance mechanism

fully furnished suites providing laboratory ► Vision group on Biotechnology
facility to promote innovation driven R&D ► Incentives for Patent registration and
start-ups green initiatives
► Biotech parks-Bengaluru Helix-setup with ► Support for Standardization certification
institutional zone, research and R&D ► Anchor Unit Subsidy for first two
institutions and Bio-cluster manufacturing enterprises
► Incentives for Export Oriented MSME,
Large, and Mega Project, like 100%
exemption from payment of Entry Tax

3 4
Increases the quality of human Provides general infrastructure
resources by supporting specific such as high quality roads, better
educational and research institutions power supply and airports

► Institutions such as IAB, IBAB, CHG and ► Specific fiscal incentives to develop
finishing schools industrial infrastructure
► Fostering entrepreneurship and ► Land facilitation for field trials and
development of new products – Med experiments by agro-biotech enterprises
Tech, Clean Tech, nutraceutiucals, and scientists
pharmaceuticals etc.

5 6
Other Initiatives Integrated Policy Approach

► Set up VCF with private participation-
called the KBio- VEN Fund of Rs. 50
crores
► Biotech policy 2017-22 focuses on 10
emerging areas in the Biotechnology
field
► Incentives for Biotech Start-ups under
Karnataka Startup Policy 2015-20
► Fiscal incentives and concessions
offered under the prevailing Karnataka
Industrial Policy to the biotechnology
industries and R&D centres

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 20
 Conducive Policy Environment
Committee to promote private

Infrastructure
► Development of Pharmaceutical parks in
potential locations of Karnataka through PPP pharma sector
► Setting up of SEZs would be encouraged
under the provisions in the SEZ policy An Inter-Ministerial coordination
Committee to review the constraints and
issues faced by the pharma industry and
► Setting up R&D institutions to leverage the facilitate resolution of these periodically
strengths of the state pharma firms currently have to approach

R&D
► Supportive fiscal incentives and grants Drug Control Department for Licensing
would be provided for promoting R&D approvals
activities

► Focus on Mega Pharmaceutical projects Venture Capital Fund

Incentives
► Package of Incentives & concessions
offered for Investments (Industrial Policy Fund of INR 50 Crore with contribution of
2014-19) like tax benefits, stamp duty 26% from Government
exemption, green initiative benefits etc.

Formation of the Karnataka Pharmaceutical Initiatives such as quick and quality

Administrative

►
Measures

Development Council and also a Vision service from Drug Control Department
group facilitating industries
► Support for promotional activities, road
shows and sector specific events

Annexure 7 and 8 of Karnataka Industrial Policy 2014-19 aims to develop infrastructure, foster R&D and
attract mega projects in the Pharmaceutical and Medical Device sector respectively

Integrated Policy
Approach

Karnataka Industrial
Policy 2014-19

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 21
 Enhancing Karnataka’s Skill : Biotechnology

Resulting in

Robust institutional ecosystem providing wide range of courses in genetics and advance
courses for clinicians , R&D in other lines, supporting the growth of sector

Biotechnology ► 12 schools have been established for Post Graduate

Finishing Schools Diploma (8 BT Domains)
(BTFS) ► Capacity for 300 students per year

Centre for Human ► Conduct courses/workshops for scientists & clinicians

Genetics ► Address lacunae in research and education including
rare genetic disorders

Institute of ► Centre of Excellence functioning since 2001 offering

Bioinformatics and courses for PG (300 students), MSc (80 students),
Applied PhD (4-10 pursuing) and modular courses
Biotechnology (IBAB)

Leading Institutions in Karnataka

► Indian Institute of Science, Bengaluru

► National Centre for Biological
Sciences, Bengaluru
► Jawaharlal Nehru Centre for Advanced
Scientific Research, Bengaluru
► National Institute of Mental Health and
Neurosciences, Bengaluru
► Indian Institute of Horticulture
Research, Bengaluru
► Karnataka Veterinary, Animal &
Fisheries Science, University, Bidar
► University of Agriculture Sciences-
Bengaluru, Dharwad, Raichur,
Shivamogga
► Institute for Agriculture Biotechnology,
Dharwad An average of 65% of job placements of BTFS
► Central Food Technological Research students thus far across 5 years
Institute, Mysuru

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 22
 Enhancing Karnataka’s Skill: Pharma

► Research base
with presence of
CROs assisting
industry with
clinical research
and trials
50

► Pharmacists trained
under Integrated
Disease Surveillance
120 Project (IDSP) in
2015-16

61 82
► Pharmacy Colleges ► Post Graduation
providing B.Pharm Enrolment
degree to 1270 capacity for M.D.
students in the (Pharmacology)
year 2016-17 in 2016-17
Source: Economic Survey of Karnataka 2016-17

Type of institutions Number Enrolments

(Government) Large number of
Medical colleges (MBBS) 42 2,668 medical education
Ayurvedic Colleges 63 936 institutions creating
Homeopathic Colleges (BHMS) 11 253 an ecosystem for
Unani Colleges 04 81 collaboration on
Naturopathy & Yogic Services (BNYS) 04 79 product
Dental Colleges (BDS) 39 1,216 development and
Pharmacy Colleges (B.Pharm) 61 1270 trials
Farm Science 39 2,645
Source: Karnataka Examinations Authority 2017: http://kea.kar.nic.in/

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 23
 Area of Investments

► Biotech Crops (Pulses, Cereals,

Plantation crops)
Agri
► Aerobic Rice (Water saving)
Products
► Sugarcane Alternative products

► Vaccine Technologies
► Drug discovery
► Synthetic Biology Pharma
► Generic Drug
Manufacturing

► Bioremediation
Environment ► Conversion of waste to useful
products

► Biofuels
► Marine Biology Energy

► Surgical, Cardiac Stents,

Medical Catheters, Renal Tubes,
Devices Dental, orthopaedic,
ophthalmologic, laboratory
instruments, etc.

SLSWCC Approved Projects from 2013- SHLCC Approved Projects from 2013-14
14 to 2016-17 to 2016-17
7,000 6,369
2,500
6,000
1,914
5,000 2,000
1,550
4,000
1,500
3,000
2,201.21
1,000
2,000

1,000 500

0
0
Investment (in INR Cr) Employment (in Nos.)
Investment (in INR Cr) Employment (in Nos.)

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 24
 Investment Opportunities

► Initiate establishment of Incubation Centre

cum Common Instrumentation Facility to
promote Marine/Aqua Biotech
► Expert Group on Agriculture Biotechnology
(EGAB) constituted as a sub group of VGBT
(Vision Group on Biotechnology)
► Sanctioned INR 8.5 crore spread over 3
years to University of Horticulture Sciences,
Bagalkote, to carry out R&D on Tomato,
Banana, Pomegranate and Garcinia; to
develop resistance to diseases and
establishment of germplasm / gene banks
► A grant of INR 6.5 crore sanctioned has been
completely released to UAS Dharwad

► An annual incentive up to 20% of expenditure

towards clinical trials for bio availability and
bio-equivalence subject to a maximum of INR
100 lakh per clinical trial under Industrial Policy
2014-19
► Nutraceutical and Phyto pharmaceutical
Incubation Centre and Common
Instrumentation Facility, stage –II is under
development to provide space for more
incubates
► Special Incentives to Medical Devices Sector
to encourage Establishment of Medical
Devices Park
► Showcasing Karnataka Medical Devices
Sector: A grant up to 50% of the cost subject
to a maximum of INR 300 lakh to organize the
biennial event of trade show and conferences

Investment Facilitation

► Karnataka Biotechnology & Information

Technology Services (KBITS) established in
2000 facilitates Biotechnology Industries in
the state and administers incentives and
concessions to Biotechnology companies
► Karnataka Drugs and Pharmaceuticals
Manufacturers’ Association insists on 100%
implementation of Pharma Policy and Parks
► Karnataka Pharmaceutical Development Cell
(KPDC) to serve as a dedicated single point
contact for pharmaceutical sector

Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 25
Additional Chief Secretary to Principal Secretary to
Govt. of Karnataka, Health & Government,
Family Welfare Services Dept. of Information
Additional Chief Secretary​ to Govt. of Technology, Biotechnology
Karnataka, Health & Family Welfare and Science & technology
Services, #105, VI Floor, 5th Stage, M.S.Building,
I Floor, Vikas Soudha, Ambedkar Veedhi,
Bangalore - 560 001 Bengaluru - 560 001
Phone: 91-80-2225 5324 Tel: 91-80-2228 0562
Fax: 91-80-2235 3916 Fax: 91-80-2228 8340
Email: prs-hfw@karnataka.gov.in Email: itsec@bangaloreitbt.in

Commissioner for Industrial

Development and
Director of Industries & Commerce
2nd Floor, Khanija Bhavan, No.49,Race Course
Road, Bangaluru 560 001
Ph : 91-80-2238 6796,
Fax : 91-80-2238 9909
Email: commissioner@karnatakaindustry.gov.in

Managing Director Chief Executive Officer

Karnataka Udyog Mitra Invest Karnataka Forum
3rd Floor, East Wing, Khanija Bhavan, 3rd Floor, East Wing, Khanija Bhavan,
Race Course Road, Race Course Road,
Bengaluru – 560 001 Bengaluru – 560 001
Phone : 91-80-2228 2392 Phone : 91-80-2228 2392
Email: md@kumbangalore.com Email: ceo@investkarnataka.co.in

Contact Details
Vendor Development and Investor Summit 2017- Biotech, Pharmaceuticals and Medical Devices - Sector Profile 26